NM_020754.4(ARHGAP31):c.371AAG[1] (p.Glu125del) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 18, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003264348.2

Allele description [Variation Report for NM_020754.4(ARHGAP31):c.371AAG[1] (p.Glu125del)]

NM_020754.4(ARHGAP31):c.371AAG[1] (p.Glu125del)

Gene:

ARHGAP31:Rho GTPase activating protein 31 [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

3q13.33

Genomic location:

Preferred name:

NM_020754.4(ARHGAP31):c.371AAG[1] (p.Glu125del)

HGVS:

NC_000003.12:g.119380926AAG[1]
NG_007665.2:g.91554AAG[1]
NM_020754.2:c.374_376delAAG
NM_020754.4:c.371AAG[1]MANE SELECT
NP_065805.2:p.Glu125del
NC_000003.11:g.119099772_119099774del
NC_000003.11:g.119099773AAG[1]

Protein change:

E125del

Links:

dbSNP: rs774589511

NCBI 1000 Genomes Browser:

rs774589511

Molecular consequence:

NM_020754.4:c.371AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003969339	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (May 18, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003969339

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(May 18, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003969339.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.374_376delAAG (p.E125del) alteration is located in exon 4 (coding exon 4) of the ARHGAP31 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.374 and c.376, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine